K2 Principal Fund’s Core Laboratories CLB Stock Holding History

K2 Principal Fund’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-15,926	Closed	-$1.97M	–	291
2016 Q2	$1.97M	Buy	15,926 +2,012	+14%	+$243K	0.26%	86
2016 Q1	$1.56M	Buy	13,914 +11,000	+377%	+$1.14M	0.21%	96
2015 Q4	$317K	Sell	2,914 -28,042	-91%	-$3.21M	0.04%	162
2015 Q3	$3.09M	Buy	+30,956	New	+$3.37M	0.5%	50

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

K2 Principal Fund's CLB Position: Q3 2016 in Review

K2 Principal Fund sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 15,926 shares — an estimated $1.97M sold.

K2 Principal Fund first reported a position in CLB in Q3 2015 and held it in 4 quarters. The position peaked at $3.09M in Q3 2015. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

K2 Principal Fund reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
K2 Principal Fund sold 15,926 Core Laboratories shares in Q3 2016, an estimated $1.97M.
K2 Principal Fund first reported a position in Core Laboratories in Q3 2015 and held it in 4 quarters.
K2 Principal Fund's Core Laboratories position peaked at $3.09M in Q3 2015.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on K2 Principal Fund's 13F filing for Q3 2016, filed 15 Nov 2016.